Literature DB >> 33798940

Tau induces formation of α-synuclein filaments with distinct molecular conformations.

Alimohammad Hojjatian1, Anvesh K R Dasari2, Urmi Sengupta3, Dianne Taylor1, Nadia Daneshparvar1, Fatemeh Abbasi Yeganeh1, Lucas Dillard4, Brian Michael5, Robert G Griffin5, Mario J Borgnia4, Rakez Kayed3, Kenneth A Taylor1, Kwang Hun Lim6.   

Abstract

Recent structural investigation of amyloid filaments extracted from human patients demonstrated that the ex vivo filaments associated with different disease phenotypes adopt diverse molecular conformations, which are different from those of in vitro amyloid filaments. A very recent cryo-EM structural study also revealed that ex vivo α-synuclein filaments extracted from multiple system atrophy patients adopt distinct molecular structures from those of in vitro α-synuclein filaments, suggesting the presence of co-factors for α-synuclein aggregation in vivo. Here, we report structural characterizations of α-synuclein filaments formed in the presence of a potential co-factor, tau, using cryo-EM and solid-state NMR. Our cryo-EM structure of the tau-promoted α-synuclein filaments reveals some similarities to one of the previously reported polymorphs of in vitro α-synuclein filaments in the core region, while illustrating distinct conformations in the N- and C-terminal regions. The structural study highlights the conformational plasticity of α-synuclein filaments and the importance of the co-factors, requiring additional structural investigation of not only more ex vivo α-synuclein filaments, but also in vitro α-synuclein filaments formed in the presence of diverse co-factors. The comparative structural analyses will help better understand molecular basis of diverse structures of α-synuclein filaments and possible relevance of each structure to the disease phenotype.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryo-EM; Solid-state NMR; Tau; α-Synuclein

Mesh:

Substances:

Year:  2021        PMID: 33798940      PMCID: PMC8062303          DOI: 10.1016/j.bbrc.2021.03.091

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Alpha-synuclein and neurodegenerative diseases.

Authors:  M Goedert
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.

Authors:  Lani K Clinton; Mathew Blurton-Jones; Kristoffer Myczek; John Q Trojanowski; Frank M LaFerla
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

4.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

5.  Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations.

Authors:  Xiaodan Ni; Ryan P McGlinchey; Jiansen Jiang; Jennifer C Lee
Journal:  J Mol Biol       Date:  2019-07-08       Impact factor: 5.469

6.  Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel.

Authors:  Binsen Li; Peng Ge; Kevin A Murray; Phorum Sheth; Meng Zhang; Gayatri Nair; Michael R Sawaya; Woo Shik Shin; David R Boyer; Shulin Ye; David S Eisenberg; Z Hong Zhou; Lin Jiang
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

7.  Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy.

Authors:  Ricardo Guerrero-Ferreira; Nicholas Mi Taylor; Ana-Andreea Arteni; Pratibha Kumari; Daniel Mona; Philippe Ringler; Markus Britschgi; Matthias E Lauer; Ali Makky; Joeri Verasdonck; Roland Riek; Ronald Melki; Beat H Meier; Anja Böckmann; Luc Bousset; Henning Stahlberg
Journal:  Elife       Date:  2019-12-09       Impact factor: 8.140

8.  Site-specific perturbations of alpha-synuclein fibril structure by the Parkinson's disease associated mutations A53T and E46K.

Authors:  Luisel R Lemkau; Gemma Comellas; Shin W Lee; Lars K Rikardsen; Wendy S Woods; Julia M George; Chad M Rienstra
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

9.  Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy.

Authors:  Julia E Gerson; Kathleen M Farmer; Natalie Henson; Diana L Castillo-Carranza; Mariana Carretero Murillo; Urmi Sengupta; Alan Barrett; Rakez Kayed
Journal:  Mol Neurodegener       Date:  2018-03-15       Impact factor: 14.195

10.  Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Dustin J Covell; Coraima Medellin; Anna Stieber; John L Robinson; Bin Zhang; Rose M Pitkin; Modupe F Olufemi; Kelvin C Luk; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nature       Date:  2018-05-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.